Long-term results of St. Jude Medical valve in the tricuspid position
Little is known of the St. Jude Medical heart valve's long-term clinical performance in the tricuspid position. Fourteen patients underwent tricuspid valve replacement between 1981 and 1984. Ages of the patients ranged from 32 to 81 years. Eight patients (68%) were in New York Heart Association...
Gespeichert in:
| Veröffentlicht in: | The Annals of thoracic surgery 1992-09, Vol.54 (3), p.538-540 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 540 |
|---|---|
| container_issue | 3 |
| container_start_page | 538 |
| container_title | The Annals of thoracic surgery |
| container_volume | 54 |
| creator | Singh, Arun K. Feng, William C. Sanofsky, Stephen J. |
| description | Little is known of the St. Jude Medical heart valve's long-term clinical performance in the tricuspid position. Fourteen patients underwent tricuspid valve replacement between 1981 and 1984. Ages of the patients ranged from 32 to 81 years. Eight patients (68%) were in New York Heart Association class IV preoperatively. Twelve patients had other concomitant cardiac operations. One patient (8%) died within 30 days after operation, due to cerebrovascular accident. Postoperatively, all patients were anticoagulated with warfarin sodium and showed improvement in functional class. There were no mechanical valve failures or thromboses in patients on the anticoagulation regimen. Follow-up in all patients extended over 7 to 10 years with a mean of 8 years. There were six late deaths unrelated to valve function. The actuarial survival curve with these patients is 50% over 10 years. In conclusion, the St. Jude Medical valve is a good mechanical substitute in the tricuspid position, and we recommend its use when reconstruction is not possible and there is no contraindication for anticoagulation. |
| doi_str_mv | 10.1016/0003-4975(92)90450-I |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73154584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000349759290450I</els_id><sourcerecordid>73154584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-54190ef6df1a45684ddea43aed3ab24b4678786ba59c4d49840df9e87240083d3</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoOl7eQCELEV10TNKkbTaCDF5GRlyo65BJTjXSacckHfDtTZ1Bd64Oh_87Fz6EjikZU0KLS0JInnFZinPJLiThgmTTLTSiQrCsYEJuo9Evsof2Q_hILUvxLtqlghLB2AjdzLr2LYvgF9hD6JsYcFfj5zjGD70F_AjWGd3glW5WgF2L4zvg6J3pw9JZvOyCi65rD9FOrZsAR5t6gF5vb14m99ns6W46uZ5lhhdlzASnkkBd2JpqLoqKWwua5xpsrueMzxNUlVUx10IabrmsOLG1hKpknJAqt_kBOlvvXfrus4cQ1cIFA02jW-j6oMqcCi4qnkC-Bo3vQvBQq6V3C-2_FCVqsKcGNWpQoyRTP_bUNI2dbPb38wXYv6G1rpSfbnIdkpba69a48IsJUYhcDtev1hgkFysHXgXjoDVJpgcTle3c_398A-H4idk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73154584</pqid></control><display><type>article</type><title>Long-term results of St. Jude Medical valve in the tricuspid position</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Singh, Arun K. ; Feng, William C. ; Sanofsky, Stephen J.</creator><creatorcontrib>Singh, Arun K. ; Feng, William C. ; Sanofsky, Stephen J.</creatorcontrib><description>Little is known of the St. Jude Medical heart valve's long-term clinical performance in the tricuspid position. Fourteen patients underwent tricuspid valve replacement between 1981 and 1984. Ages of the patients ranged from 32 to 81 years. Eight patients (68%) were in New York Heart Association class IV preoperatively. Twelve patients had other concomitant cardiac operations. One patient (8%) died within 30 days after operation, due to cerebrovascular accident. Postoperatively, all patients were anticoagulated with warfarin sodium and showed improvement in functional class. There were no mechanical valve failures or thromboses in patients on the anticoagulation regimen. Follow-up in all patients extended over 7 to 10 years with a mean of 8 years. There were six late deaths unrelated to valve function. The actuarial survival curve with these patients is 50% over 10 years. In conclusion, the St. Jude Medical valve is a good mechanical substitute in the tricuspid position, and we recommend its use when reconstruction is not possible and there is no contraindication for anticoagulation.</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/0003-4975(92)90450-I</identifier><identifier>PMID: 1510522</identifier><identifier>CODEN: ATHSAK</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Female ; Follow-Up Studies ; Heart Valve Prosthesis ; Humans ; Male ; Medical sciences ; Middle Aged ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Tricuspid Valve - surgery</subject><ispartof>The Annals of thoracic surgery, 1992-09, Vol.54 (3), p.538-540</ispartof><rights>1992 The Society of Thoracic Surgeons</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-54190ef6df1a45684ddea43aed3ab24b4678786ba59c4d49840df9e87240083d3</citedby><cites>FETCH-LOGICAL-c467t-54190ef6df1a45684ddea43aed3ab24b4678786ba59c4d49840df9e87240083d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5565394$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1510522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh, Arun K.</creatorcontrib><creatorcontrib>Feng, William C.</creatorcontrib><creatorcontrib>Sanofsky, Stephen J.</creatorcontrib><title>Long-term results of St. Jude Medical valve in the tricuspid position</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Little is known of the St. Jude Medical heart valve's long-term clinical performance in the tricuspid position. Fourteen patients underwent tricuspid valve replacement between 1981 and 1984. Ages of the patients ranged from 32 to 81 years. Eight patients (68%) were in New York Heart Association class IV preoperatively. Twelve patients had other concomitant cardiac operations. One patient (8%) died within 30 days after operation, due to cerebrovascular accident. Postoperatively, all patients were anticoagulated with warfarin sodium and showed improvement in functional class. There were no mechanical valve failures or thromboses in patients on the anticoagulation regimen. Follow-up in all patients extended over 7 to 10 years with a mean of 8 years. There were six late deaths unrelated to valve function. The actuarial survival curve with these patients is 50% over 10 years. In conclusion, the St. Jude Medical valve is a good mechanical substitute in the tricuspid position, and we recommend its use when reconstruction is not possible and there is no contraindication for anticoagulation.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart Valve Prosthesis</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Tricuspid Valve - surgery</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKxDAUhoMoOl7eQCELEV10TNKkbTaCDF5GRlyo65BJTjXSacckHfDtTZ1Bd64Oh_87Fz6EjikZU0KLS0JInnFZinPJLiThgmTTLTSiQrCsYEJuo9Evsof2Q_hILUvxLtqlghLB2AjdzLr2LYvgF9hD6JsYcFfj5zjGD70F_AjWGd3glW5WgF2L4zvg6J3pw9JZvOyCi65rD9FOrZsAR5t6gF5vb14m99ns6W46uZ5lhhdlzASnkkBd2JpqLoqKWwua5xpsrueMzxNUlVUx10IabrmsOLG1hKpknJAqt_kBOlvvXfrus4cQ1cIFA02jW-j6oMqcCi4qnkC-Bo3vQvBQq6V3C-2_FCVqsKcGNWpQoyRTP_bUNI2dbPb38wXYv6G1rpSfbnIdkpba69a48IsJUYhcDtev1hgkFysHXgXjoDVJpgcTle3c_398A-H4idk</recordid><startdate>19920901</startdate><enddate>19920901</enddate><creator>Singh, Arun K.</creator><creator>Feng, William C.</creator><creator>Sanofsky, Stephen J.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19920901</creationdate><title>Long-term results of St. Jude Medical valve in the tricuspid position</title><author>Singh, Arun K. ; Feng, William C. ; Sanofsky, Stephen J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-54190ef6df1a45684ddea43aed3ab24b4678786ba59c4d49840df9e87240083d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart Valve Prosthesis</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Tricuspid Valve - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Arun K.</creatorcontrib><creatorcontrib>Feng, William C.</creatorcontrib><creatorcontrib>Sanofsky, Stephen J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Arun K.</au><au>Feng, William C.</au><au>Sanofsky, Stephen J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term results of St. Jude Medical valve in the tricuspid position</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>1992-09-01</date><risdate>1992</risdate><volume>54</volume><issue>3</issue><spage>538</spage><epage>540</epage><pages>538-540</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><coden>ATHSAK</coden><abstract>Little is known of the St. Jude Medical heart valve's long-term clinical performance in the tricuspid position. Fourteen patients underwent tricuspid valve replacement between 1981 and 1984. Ages of the patients ranged from 32 to 81 years. Eight patients (68%) were in New York Heart Association class IV preoperatively. Twelve patients had other concomitant cardiac operations. One patient (8%) died within 30 days after operation, due to cerebrovascular accident. Postoperatively, all patients were anticoagulated with warfarin sodium and showed improvement in functional class. There were no mechanical valve failures or thromboses in patients on the anticoagulation regimen. Follow-up in all patients extended over 7 to 10 years with a mean of 8 years. There were six late deaths unrelated to valve function. The actuarial survival curve with these patients is 50% over 10 years. In conclusion, the St. Jude Medical valve is a good mechanical substitute in the tricuspid position, and we recommend its use when reconstruction is not possible and there is no contraindication for anticoagulation.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>1510522</pmid><doi>10.1016/0003-4975(92)90450-I</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-4975 |
| ispartof | The Annals of thoracic surgery, 1992-09, Vol.54 (3), p.538-540 |
| issn | 0003-4975 1552-6259 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73154584 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adult Aged Aged, 80 and over Biological and medical sciences Female Follow-Up Studies Heart Valve Prosthesis Humans Male Medical sciences Middle Aged Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Tricuspid Valve - surgery |
| title | Long-term results of St. Jude Medical valve in the tricuspid position |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A59%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20results%20of%20St.%20Jude%20Medical%20valve%20in%20the%20tricuspid%20position&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Singh,%20Arun%20K.&rft.date=1992-09-01&rft.volume=54&rft.issue=3&rft.spage=538&rft.epage=540&rft.pages=538-540&rft.issn=0003-4975&rft.eissn=1552-6259&rft.coden=ATHSAK&rft_id=info:doi/10.1016/0003-4975(92)90450-I&rft_dat=%3Cproquest_cross%3E73154584%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73154584&rft_id=info:pmid/1510522&rft_els_id=000349759290450I&rfr_iscdi=true |